PRESS RELEASE published on 02/01/2024 at 14:10, 1 year 10 months ago CORRECTION BY SOURCE: Corporate Update on Clinical Evaluation of MedMira's Products MedMira Inc. provides an update on its submission to Health Canada, extending its intended use to address the increasing need in maternity screening. The company's syphilis component demonstrates promising results, with plans to submit a comprehensive dataset for additional claims approval by February 2024 MedMira Inc. Maternity Screening Health Canada Syphilis Comprehensive Dataset
PRESS RELEASE published on 02/01/2024 at 13:35, 1 year 10 months ago Corporate Update on Clinical Evaluation of MedMira’s Products MedMira Inc. provides update on Health Canada review process for maternity screening, highlighting increasing need due to rising syphilis infection rates. Company's syphilis test performance shows promising results for infectious case detection and maternity screening MedMira Inc. Health Canada Review Maternity Screening Syphilis Infection Rates Test Performance
PRESS RELEASE published on 12/30/2023 at 05:00, 1 year 11 months ago MedMira Reports First Quarter Results FY2024 MedMira Inc. (TSXV:MIR) has reported its financial results for the quarter ended October 31, 2023. The company achieved significant milestones during this period, including receiving US FDA 510(k) clearance for the HIV-2 claim on its Reveal® G4 Rapid HIV 1/2 antibody test. This approval positions MedMira as a key player in the HIV testing market and allows the company to expand its market share and revenue in the United States.
PRESS RELEASE published on 12/14/2023 at 04:30, 1 year 11 months ago U.S. FDA Approves MedMira's Advanced Reveal G4 Rapid HIV-1/2 Antibody Test
PRESS RELEASE published on 11/29/2023 at 05:00, 2 years ago MedMira Reports FY2023 Fourth Quarter and Year End Financial Results
PRESS RELEASE published on 09/28/2023 at 04:00, 2 years 2 months ago Update on MedMira’s Regulatory Path in Canada and the USA
PRESS RELEASE published on 06/30/2023 at 04:00, 2 years 5 months ago MedMira Reports Third Quarter Results FY2023
PRESS RELEASE published on 04/04/2023 at 03:00, 2 years 8 months ago MedMira Reports Second Quarter Results FY2023
PRESS RELEASE published on 03/14/2023 at 21:31, 2 years 8 months ago Update on MedMira’s Reveal TP (Syphilis) Clinical Trials in Canada
Published on 12/05/2025 at 02:35, 10 hours 22 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 11 hours 57 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 13 hours 52 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 13 hours 57 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 12:05, 52 minutes ago Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 57 minutes ago CGTN:Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre
Published on 12/05/2025 at 12:00, 57 minutes ago Iute Group: Successful Issue of Additional EUR 2025/2030 Bonds – Circulating Volume Increased to EUR 160 Million
Published on 12/05/2025 at 11:14, 1 hour 43 minutes ago Halfords Group PLC: Director/PDMR Shareholding
Published on 12/05/2025 at 11:08, 1 hour 49 minutes ago Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 12/05/2025 at 08:45, 4 hours 12 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 4 hours 12 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 4 hours 15 minutes ago ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 18 hours 43 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 18 hours 57 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025